Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
No Data
RAPP Advances RAP-219 Into Phase 3, Raising the Stakes in Focal Epilepsy
BTIG Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $65
BTIG Reaffirms Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)
BTIG Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Raises Target Price to $65
BTIG Maintains Buy on Rapport Therapeutics, Raises Price Target to $65
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference